GNI Group Ltd.
- SEC CIK
- 0001958461
No open-market purchases or sales filed in the past year.
Current role at each company
- GYRE Gyre Therapeutics, Inc.10% Owneras of May 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists GNI Group Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2023 (view filing)9:56 PM ET | Oct 27 | 4 days | GNI Group Ltd. and 1 other10% Owner | PPurchase | +811.0K | $4.92 | +$3.99M | –13.2K after | Derivative |
| Oct 31, 2023 (view filing)9:56 PM ET | Oct 27 | 4 days | GNI Group Ltd. and 1 other10% Owner | PPurchaseSeries X Convertible Preferred Stock | +811 | $1,250.05 | +$1.01M | –8.11M after | Derivative |